JP2013544781A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013544781A5 JP2013544781A5 JP2013533102A JP2013533102A JP2013544781A5 JP 2013544781 A5 JP2013544781 A5 JP 2013544781A5 JP 2013533102 A JP2013533102 A JP 2013533102A JP 2013533102 A JP2013533102 A JP 2013533102A JP 2013544781 A5 JP2013544781 A5 JP 2013544781A5
- Authority
- JP
- Japan
- Prior art keywords
- nasal
- nose
- carrier material
- powder
- microns
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012876 carrier material Substances 0.000 description 2
- 210000001331 nose Anatomy 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 239000007923 nasal drop Substances 0.000 description 1
- 229940100662 nasal drops Drugs 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102010048374.5 | 2010-10-13 | ||
| DE102010048374A DE102010048374A1 (de) | 2010-10-13 | 2010-10-13 | Pyrrolidinone als MetAP-2 Inhibitoren |
| PCT/EP2011/004608 WO2012048775A1 (de) | 2010-10-13 | 2011-09-14 | Pyrrolidinone als metap-2 inhibitoren |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013544781A JP2013544781A (ja) | 2013-12-19 |
| JP2013544781A5 true JP2013544781A5 (cg-RX-API-DMAC7.html) | 2016-02-25 |
| JP5931885B2 JP5931885B2 (ja) | 2016-06-08 |
Family
ID=44677838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013533102A Active JP5931885B2 (ja) | 2010-10-13 | 2011-09-14 | ＭｅｔＡＰ２阻害剤としてのピロリジノン |
Country Status (23)
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8575349B2 (en) * | 2010-11-22 | 2013-11-05 | International Flavors & Fragrances Inc. | Derivatives of 1-alkyl-6-oxo-piperidine-3-carboxylic acids and 1-alkyl-5-oxo-pyrrolidine-3-carboxylic acids and their uses as cooling compounds |
| SI2573073T1 (sl) * | 2011-09-26 | 2015-02-27 | Sanofi | Pirazolokinolinonski derivati, njihova priprava in njihova terapevtska uporaba |
| JP6042060B2 (ja) * | 2011-09-26 | 2016-12-14 | サノフイ | ピラゾロキノリノン誘導体、その調製および治療上の使用 |
| DE102012006884A1 (de) * | 2012-04-04 | 2013-10-10 | Merck Patent Gmbh | Cyclische Amide als MetAP-2 Inhibitoren |
| EP3045448A4 (en) * | 2013-09-12 | 2017-01-25 | Sumitomo Chemical Company Limited | Nitrogen-containing saturated heterocyclic compound |
| SI3177603T1 (sl) | 2014-08-04 | 2019-02-28 | Merck Patent Gmbh | Derivati pirolidinona kot inhibitorji METAP-2 |
| WO2017004797A1 (en) * | 2015-07-08 | 2017-01-12 | Eli Lilly And Company | Pyrrolidinone compounds |
| WO2017084096A1 (en) * | 2015-11-20 | 2017-05-26 | Eli Lilly And Company | Pyrrolidinone compounds |
| AU2017280099A1 (en) * | 2016-06-21 | 2019-01-17 | The University Of Melbourne | Activators of HIV latency |
| WO2018098781A1 (en) * | 2016-12-01 | 2018-06-07 | Eli Lilly And Company | Pyrrolidinone compounds |
| EP3689870B1 (en) * | 2017-09-27 | 2022-07-13 | Kagoshima University | Analgesic drug using pac1 receptor antagonistic drug |
| CN108409630B (zh) * | 2018-02-07 | 2021-01-15 | 宁波大学 | 一种水相中3-羟基-2-吲哚酮衍生物的制备方法 |
| JP2022521453A (ja) * | 2019-01-22 | 2022-04-08 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 複素環式の誘導体 |
| IL289479B2 (en) * | 2019-07-03 | 2025-06-01 | Merck Patent Gmbh | Process for manufacturing (S)-3-hydroxy-1-(1H-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide |
| CN112480100B (zh) * | 2019-09-11 | 2022-10-14 | 康威(广州)生物科技有限公司 | 吡咯烷酮衍生物 |
| CN110759843A (zh) * | 2019-09-30 | 2020-02-07 | 东北师范大学 | 一种氟叠氮取代的四元杂环化合物的制备和应用 |
| US20230248695A1 (en) | 2020-07-09 | 2023-08-10 | Merck Patent Gmbh | Combinations of cancer therapeutics |
| CN112851561A (zh) * | 2021-01-29 | 2021-05-28 | 南京艾美斐生物医药科技有限公司 | 一种nr6a1蛋白受体抑制剂及其制备和应用 |
| WO2022206350A1 (en) * | 2021-03-28 | 2022-10-06 | Canwell Biotech Limited | Metap-2 inhibitors, pharmaceutical compositions and therapeutic methods thereof |
| WO2023144053A1 (en) | 2022-01-26 | 2023-08-03 | Merck Patent Gmbh | Heterocyclic derivatives |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5747469A (en) | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
| GB9904387D0 (en) | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
| UY26664A1 (es) | 2000-04-14 | 2001-11-30 | Abbott Lab | Hidrazidas y alcoxiamidas inhibidoras de la angiogénesis. |
| US20070161570A1 (en) | 2000-11-01 | 2007-07-12 | Praecis Pharmaceuticals, Inc. | Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| JP2004535377A (ja) | 2001-04-03 | 2004-11-25 | スミスクライン・ビーチャム・コーポレイション | Ｍｅｔａｐ２を阻害する方法 |
| US20030225054A1 (en) * | 2002-06-03 | 2003-12-04 | Jingwu Duan | Combined use of tace inhibitors and COX2 inhibitors as anti-inflammatory agents |
| CA2502478A1 (en) * | 2002-10-18 | 2004-05-06 | Basf Aktiengesellschaft | 1-phenylpyrrolidine-2-one-3-carboxamides |
| JP2006104280A (ja) | 2004-10-04 | 2006-04-20 | Toyo Tire & Rubber Co Ltd | 高熱伝導性加硫ゴム成形体及びダイアフラム |
| US20090264650A1 (en) | 2005-03-31 | 2009-10-22 | Nobuo Cho | Prophylactic/Therapeutic Agent for Diabetes |
| US20070123508A1 (en) | 2005-05-27 | 2007-05-31 | Roger Olsson | PAR2-modulating compounds and their use |
| UY31984A (es) | 2008-07-16 | 2010-02-26 | Boehringer Ingelheim Int | DERIVADOS DE 1-(3,4-difluorobencil)-6-oxo-1,6-dihidropirimidin-5-carboxamidas N-sustituidas y de 2-(3,4-difluorobencil)-3-oxo-2,3-dihidro-1H-pirazol-4-carboxamidas N-sustituidas. |
| CN102791699B (zh) | 2010-01-08 | 2016-04-06 | 扎夫根公司 | 烟曲霉醇型化合物和其制造和使用方法 |
| US8815309B2 (en) | 2010-01-08 | 2014-08-26 | Zafgen, Inc. | Methods of treating a subject with benign prostate hyperplasia |
-
2010
- 2010-10-13 DE DE102010048374A patent/DE102010048374A1/de not_active Withdrawn
-
2011
- 2011-09-14 EP EP11761005.5A patent/EP2627631B1/de active Active
- 2011-09-14 KR KR1020137011998A patent/KR101803126B1/ko active Active
- 2011-09-14 ES ES11761005T patent/ES2563317T3/es active Active
- 2011-09-14 PL PL11761005T patent/PL2627631T3/pl unknown
- 2011-09-14 EA EA201300442A patent/EA022299B1/ru not_active IP Right Cessation
- 2011-09-14 AU AU2011316199A patent/AU2011316199B2/en active Active
- 2011-09-14 JP JP2013533102A patent/JP5931885B2/ja active Active
- 2011-09-14 RS RS20160123A patent/RS54629B1/sr unknown
- 2011-09-14 CA CA2814369A patent/CA2814369C/en active Active
- 2011-09-14 SG SG2013026133A patent/SG189853A1/en unknown
- 2011-09-14 CN CN201180049753.6A patent/CN103153951B/zh active Active
- 2011-09-14 BR BR112013008886-9A patent/BR112013008886B1/pt active IP Right Grant
- 2011-09-14 HU HUE11761005A patent/HUE027149T2/en unknown
- 2011-09-14 WO PCT/EP2011/004608 patent/WO2012048775A1/de not_active Ceased
- 2011-09-14 DK DK11761005.5T patent/DK2627631T3/en active
- 2011-09-14 MX MX2013004004A patent/MX2013004004A/es unknown
- 2011-09-14 HR HRP20160249TT patent/HRP20160249T1/hr unknown
- 2011-09-14 US US13/878,574 patent/US8895535B2/en active Active
- 2011-09-14 SI SI201130753T patent/SI2627631T1/sl unknown
- 2011-10-13 AR ARP110103781A patent/AR083402A1/es not_active Application Discontinuation
-
2013
- 2013-04-08 IL IL225626A patent/IL225626A0/en active IP Right Grant
-
2016
- 2016-03-15 CY CY20161100221T patent/CY1117287T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013544781A5 (cg-RX-API-DMAC7.html) | ||
| JP2014526447A5 (cg-RX-API-DMAC7.html) | ||
| JP2014509313A5 (cg-RX-API-DMAC7.html) | ||
| JP2013534227A5 (cg-RX-API-DMAC7.html) | ||
| JP2015505541A5 (cg-RX-API-DMAC7.html) | ||
| JP2013541565A5 (cg-RX-API-DMAC7.html) | ||
| BR122021002471B8 (pt) | Dispositivo de distribuição de droga nasal | |
| WO2014074797A8 (en) | Ultra low density pulmonary powders | |
| WO2013155201A3 (en) | Spray ejector mechanisms and devices providing charge isolation and controllable droplet charge, and low dosage volume opthalmic administration | |
| JP2014528470A5 (cg-RX-API-DMAC7.html) | ||
| EA201590286A1 (ru) | Аэрозольное ингаляционное устройство | |
| CL2013000958A1 (es) | Dispositivo atomizador nasal para la administracion de una formulacion farmaceutica a traves de la cavidad nasal en dosis controladas, comprende: un cartucho de aerosol presurizado que a su vez incluye un frasco con una formulacion farmaceutica, el accionador comprende una salida de administracion para el penacho de aerosol, donde el orificio de descarga se encuentra dispuesto de manera de dirigir el penacho de aerosol a traves de la salida de administracion; uso. | |
| TN2015000395A1 (en) | Respirable agglomerates of porous carrier particles and micronized drug | |
| JP2013538214A5 (cg-RX-API-DMAC7.html) | ||
| UA107499C2 (uk) | Склад сухого порошку, який містить антимускариновий засіб | |
| MY191380A (en) | Stabilized fixed dose drug composition having mometasone and olopatadine | |
| JP2014530231A5 (cg-RX-API-DMAC7.html) | ||
| WO2013038268A8 (en) | Tamper resistant immediate release formulations | |
| EA201401354A1 (ru) | Новая дозированная форма и препарат, содержащий абедитерол | |
| GB201118188D0 (en) | Manufacture of medicinal aerosol canisters | |
| WO2012047182A3 (en) | Single dose dry powder inhalation device | |
| EP4233874A3 (en) | Acetylsalicylic acid for reducing the risk of a thromboembolic event | |
| EA201700182A1 (ru) | Состав для повышения стабильности лекарственного препарата, содержащий по меньшей мере один сухой порошок, полученный распылительной сушкой | |
| EA201590734A8 (ru) | Вдыхаемые лекарственные средства | |
| WO2011093815A3 (en) | Pharmaceutical compositions comprising formoterol and mometasone |